Flair Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Flair Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Flair Trial Today - Breaking & Trending Today

MRD-Guided Ibrutinib Plus Venetoclax Improves Survival in Treatment-Naive CLL

Published: December 11, 2023

Ibrutinib plus venetoclax, given at a duration determined by minimal residual disease, improved progression-free survival and overall survival vs fludarabine, cyclophosphamide, and rituximab in patients with treatment-naive chronic lymphocytic leukemia.

Source: onclive.com

Related Topics:

United KingdomInternational Working GroupPeter HillmenLeeds Teaching HospitalsChronic Lymphocytic LeukemiaFlair Trial2023 Ash Annual Meeting